World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
65243
World Ranking
8727
National Ranking
491

Ulrich Costabel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ulrich Costabel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 669 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ulrich Costabel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ulrich Costabel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ulrich Costabel is affiliated with the University of Duisburg-Essen in Germany and has a focused research profile in pulmonary and respiratory medicine. Their work primarily addresses interstitial lung diseases and idiopathic pulmonary fibrosis, where they have made significant academic contributions. Costabel's research spans 163 publications in medicine, with 94 focused on pulmonary and respiratory medicine, alongside interests in physiology, epidemiology, public health, environmental and occupational health, and pathology and forensic medicine.

The scientist's main research topics include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Inhalation and Respiratory Drug Delivery
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Occupational Exposure and Asthma
  • Medical Imaging and Pathology Studies
  • Systemic Sclerosis and Related Diseases

Frequent publication venues for Costabel include:

  • Pneumologie
  • European Respiratory Journal
  • Respiration
  • The Lancet Respiratory Medicine
  • Frontiers in Immunology

Notable recent papers by Ulrich Costabel feature prominent studies in respiratory disease management and treatment recommendations, including:

  • "Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial" (2021), published in The Lancet Respiratory Medicine
  • "Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities" (2020), published in The Lancet Respiratory Medicine
  • "Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis" (2020), published in European Respiratory Review
  • "Hypersensitivity pneumonitis" (2020), published in Nature Reviews Disease Primers
  • "Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis" (2023), published in JAMA

Costabel has collaborated extensively with several co-authors, including:

  • Francesco Bonella
  • Michael Kreuter
  • Dirk Koschel
  • Antje Prasse
  • Jürgen Behr

These collaborations have supported interdisciplinary approaches in pulmonary research, combining clinical insights and therapeutic innovation. Ulrich Costabel's scientific output reflects a field-centered investigation into chronic lung diseases, emphasizing both clinical trial participation and consensus-building efforts in treatment guidelines.

Best Publications

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

    Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • Idiopathic pulmonary fibrosis : Diagnosis and treatment. International consensus statement

    Jr King;U. Costabel;J. F. Cordier;G. A. DoPico

  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

    Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

    Hunninghake Gw;Costabel U;Ando M;Baughman R

  • High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

    Maurits Demedts;Juergen Behr;Roland Buhl;Ulrich Costabel

  • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

    Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim

  • An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

    Keith C. Meyer;Ganesh Raghu;Robert P. Baughman;Kevin K. Brown

  • Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

    Robert P. Baughman;Marjolein Drent;Mani Kavuru;Marc A. Judson

  • Clinical diagnosis of hypersensitivity pneumonitis.

    Yves Lacasse;Moises Selman;Ulrich Costabel;Jean Charles Dalphin

  • European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

    S R Johnson;J F Cordier;R Lazor;R Lazor;V Cottin

  • Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

    Talmadge E King;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.

    Yoshinobu Eishi;Moritaka Suga;Ikuo Ishige;Daisuke Kobayashi

  • Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

    Victor Corman;Marcel Müller;U. Costabel;J. Timm

  • Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool

    Marc A. Judson;Ulrich Costabel;Marjolein Drent;Athol Wells

Frequent Co-Authors

Paul W. Noble
Paul W. Noble Cedars-Sinai Medical Center
Roland M. du Bois
Roland M. du Bois Imperial College London
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Talmadge E. King
Talmadge E. King University of California, San Francisco
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Athol U. Wells
Athol U. Wells Imperial College London
Ganesh Raghu
Ganesh Raghu University of Washington
Nobuoki Kohno
Nobuoki Kohno Hiroshima University
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Steven A. Sahn
Steven A. Sahn Medical University of South Carolina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in studying Medicine in the USA have a variety of related online degree and certification pathways to consider. These options offer flexibility and can help launch or advance a healthcare career.

For those looking to become pharmacists, pharm d online programs provide accredited education that meets professional requirements while accommodating busy schedules.

Another growing field is health information management. You can pursue health information technology programs online, preparing for roles in managing electronic medical records and healthcare data.

For quick entry into the workforce, explore options for the cheapest medical coding certification online. This pathway enables job opportunities in medical billing, coding, and insurance processing.

If you’re aiming for advanced patient care roles, check out affordable np programs to become a nurse practitioner. This can open doors to higher responsibilities and salary potential in healthcare settings.

Each of these online options supports different career goals and is designed to make education more accessible and affordable for aspiring healthcare professionals.

Best Scientists Citing Ulrich Costabel

Trending Scientists

Recently Published Articles